ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 615291 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 615291; 2) Community: the network communities that were significantly associated with the response to NSC 615291; 3) Molecule: the relationships between components within communities and NSC 615291; 4) MDR: the compounds that were significantly associated with the NSC 615291.

NSC Compound Enrichment Correlation
NSC 741459 (11aS)-8-(3-[(11aS)-2,2-difluoro-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypropoxy)-2,2-difluoro-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4 0.022188614181866 0.6223655
NSC 753377 3-[2-(1-methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine 0.022188614181866 0.067239369
NSC 678131 Null 0.0235234559682125 0.10916242
NSC 688526 Null 0.0235234559682125 0.053615971
NSC 174121 Methotrexate Derivative 0.0235234559682128 0.39051635
NSC 46061 Phenothiazine, 10-[3-(4-methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-, disuccinate 0.0235234559682128 -0.022947607
NSC 117915 1H-Indole-2,3-dione, 5-methyl-,3-[2-(2-nitrophenyl)hydrazone] 0.0238174255956147 -0.15016483
NSC 1433 4-(BUTYLAMINO)-1-PHENYL-1H-PYRAZOLO[3,4-D]PYRIMIDINE 0.0238174255956147 0.017785236
NSC 256927 CHIP 0.0238174255956147 0.56445888
NSC 629867 Null 0.0238174255956147 0.25801642
Total:48  Current:24    [First] [Prev] [Next] [Last]